Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer (DARTS)
NCT04952480Phase 2Recruiting
- Sponsor
- American Health Staffing Group
- Start
- Jun 2022
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by American Health Staffing Group. Primary endpoint: Local failure rate at 24 months. Started Jun 2022; status: recruiting.
Beyond the preview
Go deeper on NCT04952480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04952480.